Literature DB >> 16391457

Familial combined hyperlipidemia in a North Indian kindred.

C S Sriram1, Sheffali Gulati, Vikas Chopra, Suman Vashist, P S N Menon.   

Abstract

Familial combined hyperlipidemia is the most common genetic hyperlipidemia and is responsible for premature coronary artery disease. It is genetically heterogenous and no single diagnostic marker exists. The authors report an affected North Indian kindred spanning three successive generations with a possible autosomal dominant pattern of inheritance and all of them had combined dyslipidemia [elevated total cholesterol, predominantly the low density lipoprotein (LDL) fraction and elevated triglycerides]. The proband, a 4-month-old male baby, was incidentally discovered to have a lipaemic serum and so further evaluated. Both the index case and his maternal grandmother, a non-obese diabetic (type 2) with hypertension, had an atherogenic lipoprotein phenotype. Lipaemia retinalis was documented in this baby but xanthomas and coronary artery disease were not noted in the kindred. The present case report highlights the failure of dietary therapy in the proband and explores new options.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16391457     DOI: 10.1007/BF02731678

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

Review 1.  Combination therapy for combined dyslipidemia.

Authors:  Antonios M Xydakis; Christie M Ballantyne
Journal:  Am J Cardiol       Date:  2002-11-20       Impact factor: 2.778

Review 2.  Lipid lowering in the young.

Authors:  G R Thompson
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

3.  Phenotype expression in familial combined hyperlipidemia.

Authors:  K V Porkka; I Nuotio; P Pajukanta; C Ehnholm; L Suurinkeroinen; M Syvänne; T Lehtimäki; A T Lahdenkari; S Lahdenperä; K Ylitalo; M Antikainen; M Perola; O T Raitakari; P Kovanen; J S Viikari; L Peltonen; M R Taskinen
Journal:  Atherosclerosis       Date:  1997-09       Impact factor: 5.162

4.  Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.

Authors:  H Allayee; K M Dominguez; B E Aouizerat; R M Krauss; J I Rotter; J Lu; R M Cantor; T W de Bruin; A J Lusis
Journal:  J Lipid Res       Date:  2000-02       Impact factor: 5.922

5.  A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia.

Authors:  Brian W McCrindle; Elizabeth Helden; Geraldine Cullen-Dean; William T Conner
Journal:  Pediatr Res       Date:  2002-06       Impact factor: 3.756

Review 6.  Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.

Authors:  J A Cortner; P M Coates; C A Liacouras; G P Jarvik
Journal:  J Pediatr       Date:  1993-08       Impact factor: 4.406

7.  Use of cholestyramine in the treatment of children with familial combined hyperlipidemia.

Authors:  C A Liacouras; P M Coates; P R Gallagher; J A Cortner
Journal:  J Pediatr       Date:  1993-03       Impact factor: 4.406

8.  Lipaemia retinalis in a 29-day-old infant with type 1 hyperlipoproteinaemia.

Authors:  S Hayasaka; T Fukuyo; M Kitaoka; H Suzuki; K Omura; Y Kondo; M Nakagawa
Journal:  Br J Ophthalmol       Date:  1985-04       Impact factor: 4.638

Review 9.  Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia.

Authors:  Amir F Ayyobi; John D Brunzell
Journal:  Am J Cardiol       Date:  2003-08-18       Impact factor: 2.778

  9 in total
  1 in total

1.  Lipemia retinalis in a 27 day old neonate: A case report.

Authors:  Noopur DeokinandanNayak Shinkre; Ugam P S Usgaonkar
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.